These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

257 related items for PubMed ID: 25288652

  • 1. Efficacy of caspofungin, a 1,3-β-D-glucan synthase inhibitor, on Pneumocystis carinii pneumonia in rats.
    Sun P, Tong Z.
    Med Mycol; 2014 Nov; 52(8):798-803. PubMed ID: 25288652
    [Abstract] [Full Text] [Related]

  • 2. [The treatment of pneumocystis Carinii pneumonia with caspofungin in elderly patients: a case report and literature review].
    Zhang JC, Dai JY, Fan J, Wu XP.
    Zhonghua Jie He He Hu Xi Za Zhi; 2006 Jul; 29(7):463-5. PubMed ID: 17045046
    [Abstract] [Full Text] [Related]

  • 3. High initial (1, 3) Beta-d-Glucan concentration may be a predictor of satisfactory response of c aspofungin combined with TMP/SMZ for HIV-negative patients with moderate to severe Pneumocystis jirovecii pneumonia.
    Jin F, Liu XH, Chen WC, Fan ZL, Wang HL.
    Int J Infect Dis; 2019 Nov; 88():141-148. PubMed ID: 31442630
    [Abstract] [Full Text] [Related]

  • 4. Successful treatment of severe Pneumocystis pneumonia in an immunosuppressed patient using caspofungin combined with clindamycin: a case report and literature review.
    Li H, Huang H, He H.
    BMC Pulm Med; 2016 Nov 11; 16(1):144. PubMed ID: 27835947
    [Abstract] [Full Text] [Related]

  • 5. [Study on the changes of soluble intercellular adhesion molecule-1 level in sera of rats infected with Pneumocystis carinii].
    Liu KQ, Yin WD, Xue GP, Zhang JS.
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2007 Feb 28; 25(1):27-31, 35. PubMed ID: 17639695
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [The experimental study of garlicin in treating Pneumocystis carinii pneumonia in rats].
    Lu ZM, Tang HW, Zhang ZM, Liu JH, Zhang JS, Zhang WZ.
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2004 Dec 28; 22(6):357-60. PubMed ID: 15830863
    [Abstract] [Full Text] [Related]

  • 8. Combination of Echinocandins and Trimethoprim/Sulfamethoxazole for the Treatment of Pneumocystis jiroveci Pneumonia After Heart Transplantation.
    Lu YM, Lee YT, Chang HC, Yang HS, Chang CY, Huang CM, Wei J.
    Transplant Proc; 2017 Oct 28; 49(8):1893-1898. PubMed ID: 28923644
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Combination of caspofungin and low-dose trimethoprim/sulfamethoxazole for the treatment of severe Pneumocystis jirovecii pneumonia in renal transplant recipients.
    Tu GW, Ju MJ, Xu M, Rong RM, He YZ, Xue ZG, Zhu TY, Luo Z.
    Nephrology (Carlton); 2013 Nov 28; 18(11):736-42. PubMed ID: 24571744
    [Abstract] [Full Text] [Related]

  • 11. Therapeutic potential of caspofungin combined with trimethoprim-sulfamethoxazole for pneumocystis pneumonia: a pilot study in mice.
    Lobo ML, Esteves F, de Sousa B, Cardoso F, Cushion MT, Antunes F, Matos O.
    PLoS One; 2013 Nov 28; 8(8):e70619. PubMed ID: 23940606
    [Abstract] [Full Text] [Related]

  • 12. Efficacy of initial caspofungin plus trimethoprim/sulfamethoxazole for severe PCP in patients without human immunodeficiency virus infection.
    Qi H, Dong D, Liu N, Xu Y, Qi M, Gu Q.
    BMC Infect Dis; 2023 Jun 16; 23(1):409. PubMed ID: 37328748
    [Abstract] [Full Text] [Related]

  • 13. Caspofungin combined with TMP/SMZ as a first-line therapy for moderate-to-severe PCP in patients with human immunodeficiency virus infection.
    Tian Q, Si J, Jiang F, Xu R, Wei B, Huang B, Li Q, Jiang Z, Zhao T.
    HIV Med; 2021 Apr 16; 22(4):307-313. PubMed ID: 33277811
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. High Prevalence of Pneumocystis jirovecii Dihydropteroate Synthase Gene Mutations in Patients with a First Episode of Pneumocystis Pneumonia in Santiago, Chile, and Clinical Response to Trimethoprim-Sulfamethoxazole Therapy.
    Ponce CA, Chabé M, George C, Cárdenas A, Durán L, Guerrero J, Bustamante R, Matos O, Huang L, Miller RF, Vargas SL.
    Antimicrob Agents Chemother; 2017 Feb 16; 61(2):. PubMed ID: 27855071
    [Abstract] [Full Text] [Related]

  • 16. A regimen based on the combination of trimethoprim/sulfamethoxazole with caspofungin and corticosteroids as a first-line therapy for patients with severe non-HIV-related pneumocystis jirovecii pneumonia: a retrospective study in a tertiary hospital.
    Li H, Lu Y, Tian G, Wu Y, Chen T, Zhang J, Hu N, Wang X, Wang Y, Gao L, Yan J, Zhou L, Shi Q.
    BMC Infect Dis; 2024 Jan 31; 24(1):152. PubMed ID: 38297200
    [Abstract] [Full Text] [Related]

  • 17. Meta-analysis of echinocandins combined with trimethoprim-sulfamethoxazole for treatment of Pneumocystis pneumonia.
    Guo J, Chen Z, Kong C, Yu B, Wang T, Zhang Y, Liu Y, Zhou J, Qiu T.
    J Chemother; 2023 May 31; 35(3):181-187. PubMed ID: 35815561
    [Abstract] [Full Text] [Related]

  • 18. A Pilot Study of Echinocandin Combination with Trimethoprim/Sulfamethoxazole and Clindamycin for the Treatment of AIDS Patients with Pneumocystis Pneumonia.
    Wang M, Lang G, Chen Y, Hu C, Guo Y, Tao R, Dong X, Zhu B.
    J Immunol Res; 2019 May 31; 2019():8105075. PubMed ID: 31886310
    [Abstract] [Full Text] [Related]

  • 19. Efficacy of once-weekly dapsone dosing for Pneumocystis jirovecii pneumonia prophylaxis post transplantation.
    Evans RA, Clifford TM, Tang S, Au T, Fugit AM.
    Transpl Infect Dis; 2015 Dec 31; 17(6):816-21. PubMed ID: 26369753
    [Abstract] [Full Text] [Related]

  • 20. Atovaquone versus trimethoprim-sulfamethoxazole as Pneumocystis jirovecii pneumonia prophylaxis following renal transplantation.
    Gabardi S, Millen P, Hurwitz S, Martin S, Roberts K, Chandraker A.
    Clin Transplant; 2012 Dec 31; 26(3):E184-90. PubMed ID: 22487221
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.